$NEXT
NextDecade Corp. Stock $next

$next Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000143774921007153 Filed on March 25, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.950M	$12.43M	$24.59M
YoY Change	-68.22%	24.92%	-32.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$50.00K	$90.00K	$251.0K
YoY Change	-44.44%	125.0%	46.78%
% of Gross Profit
Operating Expenses	$4.000M	$12.52M	$35.00M
YoY Change	-68.05%	25.33%	-18.63%
Operating Profit			-$35.00M
YoY Change			-18.63%
Interest Expense	$0.00	$530.0K	$1.718M
YoY Change	-100.0%	-1.85%	68.6%
% of Operating Profit
Other Income/Expense, Net	$1.720M	-$1.890M	-$870.0K
YoY Change	-191.01%		-182.46%
Pretax Income	-$2.280M	-$13.88M	-$35.87M
YoY Change	-83.57%	19.66%	-14.51%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.280M	-$13.88M	-$35.87M
YoY Change	-83.57%	19.66%	-14.51%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$19.36K	-$120.7K	-$328.9K
COMMON SHARES
Basic Shares Outstanding	120.5M	120.8M	109.1M
Diluted Shares Outstanding			109.1M

Balance Sheet

Concept	2020 Q4	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.61M	$77.94M	$15.70M
YoY Change	-70.99%	3.07%	390.63%
Cash & Equivalents	$22.61M	$15.74M	$15.70M
Short-Term Investments	$0.00	$62.21M
Other Short-Term Assets	$267.0K	$381.0K	$300.0K
YoY Change	-29.92%	9.17%	-40.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$23.28M	$78.80M	$16.00M
YoY Change	-70.46%	2.43%	332.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$161.7M	$134.6M	$135.6M
YoY Change	20.11%	46.18%	47.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$62.20M	$62.20M
YoY Change	-100.0%	-14.21%	-14.21%
Other Assets	$16.30M	$6.748M
YoY Change	141.54%
Total Long-Term Assets	$178.4M	$142.4M	$205.2M
YoY Change	25.28%	54.66%	24.14%
TOTAL ASSETS
Total Short-Term Assets	$23.28M	$78.80M	$16.00M
Total Long-Term Assets	$178.4M	$142.4M	$205.2M
Total Assets	$201.7M	$221.2M	$221.2M
YoY Change	-8.83%	30.88%	30.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$207.0K	$11.91M	$11.90M
YoY Change	-98.26%	1556.75%	1600.0%
Accrued Expenses	$1.500M	$9.500M	$9.500M
YoY Change	-84.21%	13.1%	13.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.143M	$21.54M	$21.40M
YoY Change	-76.13%	78.19%	135.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$22.92M	$0.00	$12.20M
YoY Change		-100.0%	16.19%
Total Long-Term Liabilities	$22.92M	$0.00	$12.20M
YoY Change		-100.0%	16.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.143M	$21.54M	$21.40M
Total Long-Term Liabilities	$22.92M	$0.00	$12.20M
Total Liabilities	$28.93M	$33.58M	$33.60M
YoY Change	-13.84%	71.93%	72.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$148.0M	-$133.7M
YoY Change	10.72%	36.96%
Common Stock	$12.00K	$12.00K
YoY Change	0.0%	9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.031M	$685.0K
YoY Change	50.51%	1857.14%
Treasury Stock Shares	$249.7B	$137.9K
Shareholders Equity	$60.43M	$89.72M	$187.6M
YoY Change
Total Liabilities & Shareholders Equity	$201.7M	$221.2M	$221.2M
YoY Change	-8.83%	30.88%	30.89%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	-$2.280M	-$13.88M	-$35.87M
YoY Change	-83.57%	19.66%	-14.51%
Depreciation, Depletion And Amortization	$50.00K	$90.00K	$251.0K
YoY Change	-44.44%	125.0%	46.78%
Cash From Operating Activities	-$3.500M	-$7.420M	-$40.70M
YoY Change	-52.83%	-30.26%	74.79%
INVESTING ACTIVITIES
Capital Expenditures	-$3.780M	-$8.570M	$20.30M
YoY Change	-55.89%	19.03%	8.82%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$21.90M	$10.49M
YoY Change	-100.0%	76.61%	-115.54%
Cash From Investing Activities	-$3.790M	-$30.48M	-$16.69M
YoY Change	-87.57%	55.51%	-80.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$650.0K
YoY Change			1757.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-40.00K	49.79M	$69.96M
YoY Change	-100.08%	-10693.62%	-9.04%
NET CHANGE
Cash From Operating Activities	-3.500M	-7.420M	-$40.70M
Cash From Investing Activities	-3.790M	-30.48M	-$16.69M
Cash From Financing Activities	-40.00K	49.79M	$69.96M
Net Change In Cash	-7.330M	11.89M	$12.57M
YoY Change	-161.65%	-138.72%	-138.63%
FREE CASH FLOW
Cash From Operating Activities	-$3.500M	-$7.420M	-$40.70M
Capital Expenditures	-$3.780M	-$8.570M	$20.30M
Free Cash Flow	$280.0K	$1.150M	-$61.00M
YoY Change	-75.65%	-133.43%	45.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	122174938
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	480000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	480000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117800000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117800000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117300000
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117300000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	249742
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	137860
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	900000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	900000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-400000	USD
CY2019Q4	us-gaap	Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent	200000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Open Tax Year OpenTaxYear	2015 2016 2017 2018 2019 2020
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22608000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15736000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	62207000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	670000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	859000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	23278000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	78802000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	161662000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134591000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	429000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1054000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16299000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6748000	USD
CY2020Q4	us-gaap	Assets Assets	201668000	USD
CY2019Q4	us-gaap	Assets Assets	221195000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	207000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11912000	USD
CY2020Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	182000	USD
CY2019Q4	us-gaap	Deferred Compensation Share Based Arrangements Liability Current DeferredCompensationShareBasedArrangementsLiabilityCurrent	182000	USD
CY2020Q4	next	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	1032000	USD
CY2019Q4	next	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	8751000	USD
CY2020Q4	next	Current Common Stock Warrant Liabilities CurrentCommonStockWarrantLiabilities	3290000	USD
CY2019Q4	next	Current Common Stock Warrant Liabilities CurrentCommonStockWarrantLiabilities	0	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	432000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	698000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5143000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21543000	USD
CY2020Q4	next	Non Current Common Stock Warrant Liabilities NonCurrentCommonStockWarrantLiabilities	874000	USD
CY2019Q4	next	Non Current Common Stock Warrant Liabilities NonCurrentCommonStockWarrantLiabilities	12034000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	22916000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Liabilities Liabilities	28933000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	33580000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1031000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	685000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	209481000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	224091000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-148030000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133701000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	60432000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	89717000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	201668000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	221195000	USD
CY2019	us-gaap	Revenues Revenues	0	USD
CY2020	us-gaap	Revenues Revenues	0	USD
CY2020	next	General And Administrative Expense Recovery GeneralAndAdministrativeExpenseRecovery	20213000	USD
CY2019	next	General And Administrative Expense Recovery GeneralAndAdministrativeExpenseRecovery	22548000	USD
CY2020	next	Bid Contract Costs Invitation BidContractCostsInvitation	0	USD
CY2019	next	Bid Contract Costs Invitation BidContractCostsInvitation	10163000	USD
CY2020	next	Land Option And Lease Expense LandOptionAndLeaseExpense	1603000	USD
CY2019	next	Land Option And Lease Expense LandOptionAndLeaseExpense	2039000	USD
CY2020	us-gaap	Depreciation Depreciation	196000	USD
CY2019	us-gaap	Depreciation Depreciation	251000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	22012000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	35001000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-22012000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-35001000	USD
CY2020	next	Gain Loss On Revaluation Of Warrants GainLossOnRevaluationOfWarrants	7870000	USD
CY2019	next	Gain Loss On Revaluation Of Warrants GainLossOnRevaluationOfWarrants	-2657000	USD
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-412000	USD
CY2019	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	243000	USD
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1718000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-18000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7683000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-870000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14329000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-35871000	USD
CY2020	us-gaap	Dividends Preferred Stock DividendsPreferredStock	14327000	USD
CY2019	us-gaap	Dividends Preferred Stock DividendsPreferredStock	11164000	USD
CY2020	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	128000	USD
CY2019	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1517000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28784000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-48552000	USD
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	117524000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	109057000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	83221000	USD
CY2019	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards	-8525000	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	495000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	61825000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	650000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	11164000	USD
CY2019	next	Adjustments To Additional Paid In Capital Deemed Dividends AdjustmentsToAdditionalPaidInCapitalDeemedDividends	-1517000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-35871000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	89717000	USD
CY2020	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards	-155000	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	346000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	14327000	USD
CY2020	next	Adjustments To Additional Paid In Capital Deemed Dividends AdjustmentsToAdditionalPaidInCapitalDeemedDividends	-128000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14329000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	60432000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-14329000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-35871000	USD
CY2020	us-gaap	Depreciation Depreciation	196000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	-9646000	USD
CY2019	us-gaap	Depreciation Depreciation	251000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	-341000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	207000	USD
CY2020	next	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-874000	USD
CY2019	next	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1624000	USD
CY2019	next	Investing Activities Other Noncurrent Assets InvestingActivitiesOtherNoncurrentAssets	6875000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	61972000	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	77000000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	188000	USD
CY2020	next	Increase Decrease In Accrued Expenses And Other Liabilities IncreaseDecreaseInAccruedExpensesAndOtherLiabilities	-5869000	USD
CY2019	next	Increase Decrease In Accrued Expenses And Other Liabilities IncreaseDecreaseInAccruedExpensesAndOtherLiabilities	1909000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26253000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40700000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32352000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20303000	USD
CY2020	next	Investing Activities Other Noncurrent Assets InvestingActivitiesOtherNoncurrentAssets	10911000	USD
CY2020	next	Gain Loss On Revaluation Of Warrants GainLossOnRevaluationOfWarrants	7870000	USD
CY2019	next	Gain Loss On Revaluation Of Warrants GainLossOnRevaluationOfWarrants	-2657000	USD
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-0	USD
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	100000	USD
CY2020	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	-423000	USD
CY2019	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	138000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1230000	USD
CY2019	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	955000	USD
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1360000	USD
CY2019	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	127000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-191000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-573000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-370000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	66515000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18521000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16693000	USD
CY2020	next	Proceeds From Divestiture Of Businesses Financing Activities ProceedsFromDivestitureOfBusinessesFinancingActivities	15000000	USD
CY2019	next	Proceeds From Divestiture Of Businesses Financing Activities ProceedsFromDivestitureOfBusinessesFinancingActivities	0	USD
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2019	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	70945000	USD
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	50000	USD
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	42000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	293000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	346000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	650000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14604000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	69960000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6872000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12567000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15736000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3169000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22608000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15736000	USD
CY2020	next	Capital Expenditures Incurred But Not Yet Paid Included In Accounts Payable CapitalExpendituresIncurredButNotYetPaidIncludedInAccountsPayable	16000	USD
CY2019	next	Capital Expenditures Incurred But Not Yet Paid Included In Accounts Payable CapitalExpendituresIncurredButNotYetPaidIncludedInAccountsPayable	11351000	USD
CY2020	next	Capital Expenditures Incurred But Not Yet Paid Included In Accrued Liabilities CapitalExpendituresIncurredButNotYetPaidIncludedInAccruedLiabilities	650000	USD
CY2019	next	Capital Expenditures Incurred But Not Yet Paid Included In Accrued Liabilities CapitalExpendituresIncurredButNotYetPaidIncludedInAccruedLiabilities	2503000	USD
CY2020	next	Pipeline Assets In Exchange For Other Non Current Liabilities PipelineAssetsInExchangeForOtherNonCurrentLiabilities	7916000	USD
CY2019	next	Pipeline Assets In Exchange For Other Non Current Liabilities PipelineAssetsInExchangeForOtherNonCurrentLiabilities	0	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2019	us-gaap	Stock Issued1 StockIssued1	12082000	USD
CY2020	next	Noncash Paidinkind Dividends Convertible Preferred Stock NoncashPaidinkindDividendsConvertiblePreferredStock	14277000	USD
CY2019	next	Noncash Paidinkind Dividends Convertible Preferred Stock NoncashPaidinkindDividendsConvertiblePreferredStock	11122000	USD
CY2020	next	Noncash Accretion Of Deemed Dividends Convertible Preferred Stock NoncashAccretionOfDeemedDividendsConvertiblePreferredStock	128000	USD
CY2019	next	Noncash Accretion Of Deemed Dividends Convertible Preferred Stock NoncashAccretionOfDeemedDividendsConvertiblePreferredStock	1517000	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Use of Estimates</b></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and the accompanying notes. Management evaluates its estimates and related assumptions regularly, including those related to the value of property, plant and equipment, income taxes including valuation allowances for net deferred tax assets, share-based compensation and fair value measurements. Changes in facts and circumstances or additional information <em style="font: inherit;"> may </em>result in revised estimates, and actual results <em style="font: inherit;"> may </em>differ from these estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"> </p>
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: -9pt;"><b>Concentrations of Credit Risk</b></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents. We maintain cash balances with a single financial institution, which <em style="font: inherit;"> may </em>at times be in excess of federally insured levels. We have <em style="font: inherit;">not</em> incurred losses related to these cash and cash equivalent balances to date.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p>
CY2020Q4	next	Prepaid Subscriptions PrepaidSubscriptions	29000	USD
CY2019Q4	next	Prepaid Subscriptions PrepaidSubscriptions	161000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	314000	USD
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	292000	USD
CY2020Q4	next	Prepaid Marketing And Sponsorships PrepaidMarketingAndSponsorships	60000	USD
CY2019Q4	next	Prepaid Marketing And Sponsorships PrepaidMarketingAndSponsorships	25000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	267000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	381000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	670000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	859000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	62207000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	6278000	USD
CY2019	us-gaap	Depreciation Depreciation	251000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	161662000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134591000	USD
CY2020	us-gaap	Depreciation Depreciation	196000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	429000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1054000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	432000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	698000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	432000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	701000	USD
CY2019	next	Land Option Lease Cost LandOptionLeaseCost	543000	USD
CY2020	us-gaap	Lease Cost LeaseCost	1603000	USD
CY2019	us-gaap	Lease Cost LeaseCost	2039000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	1275000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1175000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	319000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	321000	USD
CY2020	next	Land Option Lease Cost LandOptionLeaseCost	9000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	452000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	452000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	432000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1004000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1844000	USD
CY2020	next	Noncash Rightofuse Assets Recorded Upon Adoption Of Accounting Standard NoncashRightofuseAssetsRecordedUponAdoptionOfAccountingStandard	0	USD
CY2019	next	Noncash Rightofuse Assets Recorded Upon Adoption Of Accounting Standard NoncashRightofuseAssetsRecordedUponAdoptionOfAccountingStandard	1562000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	605000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	443000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16299000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6748000	USD
CY2020Q4	next	Permitting Costs Noncurrent PermittingCostsNoncurrent	7385000	USD
CY2019Q4	next	Permitting Costs Noncurrent PermittingCostsNoncurrent	2637000	USD
CY2020Q4	next	Enterprise Resource Planning System Noncurrent EnterpriseResourcePlanningSystemNoncurrent	1805000	USD
CY2019Q4	next	Enterprise Resource Planning System Noncurrent EnterpriseResourcePlanningSystemNoncurrent	3165000	USD
CY2020Q4	next	Site Lease Initial Direct Costs SiteLeaseInitialDirectCosts	7109000	USD
CY2019Q4	next	Site Lease Initial Direct Costs SiteLeaseInitialDirectCosts	946000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4221000	USD
CY2020Q4	next	Project Asset Costs Current ProjectAssetCostsCurrent	650000	USD
CY2019Q4	next	Project Asset Costs Current ProjectAssetCostsCurrent	2503000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1060000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	363000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	967000	USD
CY2020Q4	next	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	1032000	USD
CY2019Q4	next	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	8751000	USD
CY2020	next	Gain Loss On Revaluation Of Warrants GainLossOnRevaluationOfWarrants	7900000	USD
CY2019	next	Gain Loss On Revaluation Of Warrants GainLossOnRevaluationOfWarrants	-2700000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	117524000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109057000
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117524000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109057000
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31609000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28302000
CY2020	next	Securities Excluded From Computation Of Earnings Per Share Amount Performance Conditions SecuritiesExcludedFromComputationOfEarningsPerShareAmountPerformanceConditions	2100000
CY2019	next	Securities Excluded From Computation Of Earnings Per Share Amount Performance Conditions SecuritiesExcludedFromComputationOfEarningsPerShareAmountPerformanceConditions	3600000
CY2015Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17.50
CY2015	next	Number Of Trading Days Of Share Price NumberOfTradingDaysOfSharePrice	P20D
CY2015	next	Total Number Of Trading Days Considered TotalNumberOfTradingDaysConsidered	P30D
CY2020	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards	-155000	USD
CY2019	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards	-8525000	USD
CY2020	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Liability Awards SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostLiabilityAwards	0	USD
CY2019	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Liability Awards SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostLiabilityAwards	0	USD
CY2020	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost	-155000	USD
CY2019	next	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost	-8525000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	186000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1121000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-341000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-9646000	USD
CY2020	next	Percentage Of Fid Bonus Settlement Of Shares PercentageOfFIDBonusSettlementOfShares	1.10	pure
CY2020Q4	us-gaap	Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent	200000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3100000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4772000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.95
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	225000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.02
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	612000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5.38
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	874000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	8.08
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3511000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.05
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.02	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.07	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.03	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.02	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.20	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.26	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2020Q4	next	Deferred Tax Assets Operating Loss Carryforwards And Credits DeferredTaxAssetsOperatingLossCarryforwardsAndCredits	20698000	USD
CY2019Q4	next	Deferred Tax Assets Operating Loss Carryforwards And Credits DeferredTaxAssetsOperatingLossCarryforwardsAndCredits	15064000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3813000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3441000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	725000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1025000	USD
CY2020Q4	next	Deferred Tax Assets Common Stock Warrant Liabilities DeferredTaxAssetsCommonStockWarrantLiabilities	0	USD
CY2019Q4	next	Deferred Tax Assets Common Stock Warrant Liabilities DeferredTaxAssetsCommonStockWarrantLiabilities	524000	USD
CY2020Q4	next	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	91000	USD
CY2019Q4	next	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	147000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	54000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	21000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22669000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	19802000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2712000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	420000	USD
CY2020Q4	next	Deferred Tax Liabilities Common Stock Warrant Liabilities DeferredTaxLiabilitiesCommonStockWarrantLiabilities	1129000	USD
CY2019Q4	next	Deferred Tax Liabilities Common Stock Warrant Liabilities DeferredTaxLiabilitiesCommonStockWarrantLiabilities	-0	USD
CY2020Q4	next	Deferred Tax Liabilities Operating Leases DeferredTaxLiabilitiesOperatingLeases	1583000	USD
CY2019Q4	next	Deferred Tax Liabilities Operating Leases DeferredTaxLiabilitiesOperatingLeases	420000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2712000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	420000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	98600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	26100000	USD

Files In Submission

Name	View Source	Status
0001437749-21-007153-index-headers.html	Edgar Link	pending
0001437749-21-007153-index.html	Edgar Link	pending
0001437749-21-007153.txt	Edgar Link	pending
0001437749-21-007153-xbrl.zip	Edgar Link	pending
capturecertificateoriginal.jpg	Edgar Link	pending
capturenoteoriginal.jpg	Edgar Link	pending
ex_217961.htm	Edgar Link	pending
ex_217962.htm	Edgar Link	pending
ex_217963.htm	Edgar Link	pending
ex_217964.htm	Edgar Link	pending
ex_217965.htm	Edgar Link	pending
ex_217966.htm	Edgar Link	pending
ex_217967.htm	Edgar Link	pending
ex_217968.htm	Edgar Link	pending
ex_217969.htm	Edgar Link	pending
ex_217970.htm	Edgar Link	pending
ex_217971.htm	Edgar Link	pending
ex_217972.htm	Edgar Link	pending
ex_217973.htm	Edgar Link	pending
ex_234426.htm	Edgar Link	pending
ex_234431.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
next-20201231.xsd	Edgar Link	pending
next-20201231_cal.xml	Edgar Link	unprocessable
next-20201231_def.xml	Edgar Link	unprocessable
next-20201231_lab.xml	Edgar Link	unprocessable
next-20201231_pre.xml	Edgar Link	unprocessable
next20201231_10k.htm	Edgar Link	pending
next20201231_10k_htm.xml	Edgar Link	completed
orgchartresized.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEXT
NextDecade Corp. Stock $next

2020 Q4 Form 10-K Financial Statement

#000143774921007153 Filed on March 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEXT NextDecade Corp. Stock $next

2020 Q4 Form 10-K Financial Statement

#000143774921007153 Filed on March 25, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEXT
NextDecade Corp. Stock $next